Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cygnus Biosciences

Request full access

A Chinese gene sequencing company

Changping District, ChinaFounded 2015Biotech & Life Sciences

About Cygnus Biosciences

Cygnus Bio is a biotechnology company specializing in advanced DNA sequencing technologies. The company serves a diverse range of clients, including research institutions, healthcare providers, and pharmaceutical companies. Operating in the rapidly growing genomics market, Cygnus Bio's core product, the Cygnus S100 DNA sequencer, is designed to deliver accurate, fast, flexible, and economical sequencing solutions. The business model is centered around the sale of its proprietary sequencing hardware and consumables, as well as offering sequencing services. Revenue is generated through direct sales, service contracts, and partnerships with key industry players. Cygnus Bio aims to revolutionize the genomics field by making high-quality DNA sequencing accessible and affordable for a broad spectrum of applications.

Source: Dealroom company data

At a glance

Status
Operational
Employees
18
Open positions
5
Dealroom signal
27.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Genetics and genomics, Health Diagnostics, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jul 2025 — — Shunxi Private Equity Fund Management ↗
SERIES COther financing Mar 2023 $28M $110M Founder Hesheng Investment · Source Code Capital · CCB Private Equity Investment Management · Yuhuan State Investment ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Cygnus Biosciences website traffic

Latest recorded traffic for Cygnus Biosciences is 50 monthly website visits, down 92.5% over the last three months. Cygnus Biosciences's team grew 0% over the past year.

Latest monthly visits50 3-month web change-92.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cygnus Biosciences in the Changping District ecosystem

Live from Dealroom

The Cygnus Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Proxima Ventures
  • Zhongguancun Development Group
  • Shanghai Creation Investment
  • General Technology Venture Capital

Series B and later9 investors entered at this stage

  • Technology Holdings
  • China Structural Reform Fund
  • Guolian Securities
  • Founder Hesheng Investment
  • Source Code Capital
  • CCB Private Equity Investment Management
  • Yuhuan State Investment
  • Hetang Venture Capital
  • Shunxi Private Equity Fund Management
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cygnus Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cygnus Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.